According to Alaunos Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 4227.3. At the end of 2023 the company had a P/S ratio of > 1000.
Year | P/S ratio | Change |
---|---|---|
2023 | > 1000 | 6271.01% |
2022 | 53.4 | -90.98% |
2021 | 592 | |
2020 | N/A | |
2019 | N/A | -100% |
2018 | > 1000 | 2142.6% |
2017 | 92.0 | -10.45% |
2016 | 103 | -59.35% |
2015 | 253 | -34.49% |
2014 | 386 | -29.02% |
2013 | 543 | 25.54% |
2012 | 433 | -4.36% |
2011 | 453 | |
2010 | N/A | |
2009 | N/A |